Dimethyl Fumarate

CHEMBL2107333 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
144.1 g/mol
LogP
0.7
Phase
4

An oral medication used to treat relapsing forms of multiple sclerosis and moderate-to-severe psoriasis by activating the Nrf2 pathway, which reduces oxidative stress and has anti-inflammatory effects. In multiple sclerosis, it reduces the frequency of relapses and slows disability progression. Flushing and gastrointestinal side effects are common early in treatment, and patients require monitoring of lymphocyte counts.

分子量

144.1200 g/mol

LogP

0.70

TPSA

52.60 Ų

リピンスキーの五則

適合

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COC(=O)/C=C/C(=O)OC

InChI

InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+

Molecular Formula

C6H8O4

HBD / HBA

- / 4

回転可能結合数

4

重原子数

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

An oral medication used to treat relapsing forms of multiple sclerosis and moderate-to-severe psoriasis by activating the Nrf2 pathway, which reduces oxidative stress and has anti-inflammatory effects. In multiple sclerosis, it reduces the frequency of relapses and slows disability progression. Flushing and gastrointestinal side effects are common early in treatment, and patients require monitoring of lymphocyte counts.

Yes, Dimethyl Fumarate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107333. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 637568. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.